Evidence map›Paper›PMID 32207882›Full record

ArticleMicrobial biotechnology2020

Functional replacement of isoprenoid pathways in Rhodobacter sphaeroides.

Enrico Orsi, Jules Beekwilder, Dewi van Gelder, Adèle van Houwelingen, Gerrit Eggink, Servé W M Kengen, Ruud A Weusthuis

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Promoting Photosynthetic Production of Dammarenediol-II inInternational journal of molecular sciences · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Growth-uncoupled isoprenoid synthesis inBiotechnology for biofuels · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Enrico OrsiBioprocess Engineering, Wageningen University, 6708PB, Wageningen, The Netherlands.ORCID 0000-0002-4741-0344
Jules BeekwilderWageningen Plant Research, 6700AA, Wageningen, The Netherlands.
Dewi van GelderBioprocess Engineering, Wageningen University, 6708PB, Wageningen, The Netherlands.
Adèle van HouwelingenWageningen Plant Research, 6700AA, Wageningen, The Netherlands.
Gerrit EgginkBioprocess Engineering, Wageningen University, 6708PB, Wageningen, The Netherlands.
Servé W M KengenLaboratory of Microbiology, Wageningen University, 6708WE, Wageningen, The Netherlands.
Ruud A WeusthuisBioprocess Engineering, Wageningen University, 6708PB, Wageningen, The Netherlands.
Wageningen University & Research · NLGraduate School Experimental Plant Sciences · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in synthetic biology and metabolic engineering have proven the potential of introducing metabolic by-passes within cell factories. These pathways can provide a more efficient alternative to endogenous counterparts due to their insensitivity to host's regulatory mechanisms. In this work, we replaced the endogenous essential 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway for isoprenoid biosynthesis in the industrially relevant bacterium Rhodobacter sphaeroides by an orthogonal metabolic route. The native 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway was successfully replaced by a heterologous mevalonate (MVA) pathway from a related bacterium. The functional replacement was confirmed by analysis of the reporter molecule amorpha-4,11-diene after cultivation with [4-

Indexed as

Rhodobacter sphaeroidesSesquiterpenesMetabolic EngineeringMevalonic AcidMevalonic AcidSesquiterpenes

Identifiers

PMID32207882
PMCPMC7264872
OpenAlexW3012569809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.